Depemokimab
Depemokimab (GSK-3511294) is a long-acting anti-IL-5 monoclonal antibody. Depemokimab can be used for research of asthma[1][2].
Product Specifications
CAS Number
[2243274-14-6]
Product Name Alternative
GSK-3511294
UNSPSC
12352203
Target
Interleukin Related
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/depemokimab.html
Purity
95.24
Solubility
10 mM in DMSO
Smiles
[Depemokimab]
Molecular Weight
(145.8 kDa)
References & Citations
[1]Calzetta L, et al. Investigational Treatments in Phase I and II Clinical Trials: A Systematic Review in Asthma. Biomedicines. 2022 Sep 19;10 (9) :2330. |[2]Singh D, et al. A Phase 1 study of the long-acting anti-IL-5 monoclonal antibody GSK3511294 in patients with asthma. Br J Clin Pharmacol. 2022 Feb;88 (2) :702-712.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1361737-01 0.02 mg (E-Coli)
Recombinant Human 5'-AMP-activated protein kinase subunit gamma-3 (PRKAG3)
Ask
View Details MBS1361737-02 0.02 mg (Yeast)
Recombinant Human 5'-AMP-activated protein kinase subunit gamma-3 (PRKAG3)
Ask
View Details 
MBS1361737-03 0.1 mg (E-Coli)
Recombinant Human 5'-AMP-activated protein kinase subunit gamma-3 (PRKAG3)
Ask
View Details MBS1361737-04 0.1 mg (Yeast)
Recombinant Human 5'-AMP-activated protein kinase subunit gamma-3 (PRKAG3)
Ask
View Details